Phase 3 wins for ianalumab and dazodalibep bring targeted therapies closer for Sjögren disease as patients face diagnostic delays and high costs.
|Articles|March 15, 2019
The American Journal of Managed Care
- March 2019
- Volume 25
- Issue 3
Incorrect and Missing Author Initials in Affiliations and Authorship Information
Correction to the Trends From the Field article, “Risk Stratification for Return Emergency Department Visits Among High-Risk Patients,” published in the August 2017 issue of The American Journal of Managed Care®.
Advertisement
Am J Manag Care. 2019;25(3):140In the Trends From the Field article, “Risk Stratification for Return Emergency Department Visits Among High-Risk Patients,” published in the August 2017 issue of The American Journal of Managed Care®, an author’s initials were incorrect in the Author Affiliations and Authorship Information sections. The initials for Wei Duan-Porter, MD, PhD, should have been “WD-P.”
Additionally, the initials of another author were inadvertently omitted from the Author Affiliations section. The affiliation of Chad Kessler, MD, should have read “Ambulatory Care Service, Durham VA Medical Center (CK), Durham, NC.”
Articles in this issue
over 7 years ago
From the Editorial Board: Austin Frakt, PhDover 7 years ago
Did Medicaid Expansion Matter in States With Generous Medicaid?Advertisement
Related to this article
Patch testing in Malaysia finds contact dermatitis drivers in chronic hand eczema—nickel and fragrance allergy lead, while cosmetics raise polysensitization risk.
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
The article explores the use of dose-intensive IV iron replacement to achieve long-term hemoglobin stability in patients with moderate to severe HHT-related bleeding. The approach recognizes what the author calls "the relentless and recurrent nature of HHT-associated bleeding," and may help patients achieve better quality of life.
Although PMOS Awareness Month has ended, the conversation continues, with experts saying closing diagnostic and care gaps requires ongoing efforts.
OCT patterns help distinguish MS, NMOSD, and MOGAD after optic neuritis, while timing and protocol shape MRI's diagnostic yield, experts say.
Among people with HIV, lung cancer screening eligibility rose from 6% to 15% in 6 years, but uptake stayed under 30%.
Invivyd's VYD2311 shows superior safety and tolerability vs Comirnaty in the phase 3 LIBERTY trial, with no vaccine interference.
Advertisement
Advertisement
Trending on AJMC
1
CMS Finalizes Mandatory GLOBE Model to Test Lower Part B Drug Costs
2
Lung Cancer Screening Lags for People With HIV as Eligibility Triples
3
Dual Agonist Survodutide Delivers Up to 13.1% Weight Loss in T2D
4
VYD2311 Shows Superior Safety vs mRNA COVID-19 Vaccine
5